Related Experiment Video
Updated: May 26, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578
Amonlaya Tosukhowong1, Takeshi Zendo, Wonnop Visessanguan
1National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand. amonlaya.tos@biotec.or.th
Abstract:
Lactococcus garvieae BCC 43578 produces a novel class II bacteriocin, garvieacin Q (GarQ), 70 amino acids in length and containing a 20-amino-acid N-terminal leader peptide. It is cleaved at the Gly-Gly site to generate the mature GarQ (5,339 Da), which is especially inhibitory against Listeria monocytogenes ATCC 19115 and other L. garvieae strains.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Antibiotic Selection
Bacterial Toxins
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Bacterial DNA Synthesis
